Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of GSK Biologicals' Rotarix® (Rotavirus Vaccine, Live, Oral) Administered to a Birth Cohort in United States Health Insurance Plans

NCT00875641 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00875641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00875641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of GSK Biologicals' Rotarix® (Rotavirus Vaccine, Live, Oral) Administered to a Birth Cohort in United States Health Insurance Plans
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
April 20, 2009
Completion date
November 4, 2016
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, rotavirus